Kunming Pharmaceuticals, Inc.
Clinical trials sponsored by Kunming Pharmaceuticals, Inc., explained in plain language.
-
Could a malaria pill clear discoid lupus? new trial launches
Disease control Not yet recruitingThis study tests whether dihydroartemisinin, a drug used for malaria, can safely reduce skin lesions in people with discoid lupus erythematosus (DLE). About 100 adults aged 18-65 with DLE will receive either the study drug or an active comparator for 24 weeks. The main goal is to…
Phase: PHASE2 • Sponsor: Kunming Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Could a Plant-Based injection help with delirium? early safety trial begins
Symptom relief Not yet recruitingThis early-stage study tests a new injection called gastrodin in 54 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use it to treat delirium, a sudden confusion often seen in hospital patients. This trial focuses only on safety and dru…
Phase: PHASE1 • Sponsor: Kunming Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:22 UTC